← Home
📌 Key Metrics
Pay attention and research significant changes from year to year values. [ ! ]
| Market Cap | Enterprise Value | Net Income Per Share | Revenue Per Share | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Book Value Per Share | Shareholders Equity Per Share | Tangible Book Value Per Share | Tangible Asset Value | Net Current Asset Value | Working Capital | Invested Capital | ROE | ROIC | Return On Tangible Assets | Income Quality | Debt To Equity | Debt To Assets | Net Debt To EBITDA | Interest Debt Per Share | Interest Coverage | P/E Ratio | Earnings Yield | Price To Sales Ratio | PFCF Ratio | POCF ratio | P/B Ratio | PTB Ratio | EV To Operating Cash Flow | EV To Free Cash Flow | EV To Sales | Enterprise Value Over EBITDA | Free Cash Flow Yield | Dividend Yield | Payout Ratio | CAPEX Per Share | CAPEX To Operating Cash Flow | CAPEX To Revenue | CAPEX To Depreciation | Sales General And Administrative To Revenue | R&D To Revenue | Stock Based Compensation To Revenue | Current Ratio | Days Sales Outstanding | Days Payables Outstanding | Days Of Inventory On Hand | Receivables Turnover | Payables Turnover | Inventory Turnover | Average Receivables | Average Payables | Average Inventory | Graham Number | Graham Net-Net | Intangables To Total Assets | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12 | 13.01 B | 12.902 B | 3.3699 | 34.5035 | 6.6831 | 3.8405 | 4.8307 | 34.8104 | 34.7774 | 25.2363 | 2.977 B | 1.072 B | 1.476 B | 4.262 B | 0.0969 | 0.0912 | 0.0894 | 1.9831 | 0.1124 | 0.0827 | -0.1084 | 3.9117 | 0.0 | 32.7301 | 0.0305 | 3.1967 | 28.7201 | 16.5041 | 3.1715 | 3.1715 | 16.3666 | 28.4808 | 3.1701 | 12.9069 | 0.0348 | 0.0081 | 0.2669 | 2.8426 | 0.4253 | 0.0823 | 0.7648 | 0 | 0 | 0.0 | 2.386 | 90 | 49.6247 | 181.7047 | 4.0259 | 7.3552 | 2.0087 | 934.25 M | 267.25 M | 998.5 M | 51.3515 | 2.875 | 0.2025 |
| 2024-12 | 12.189 B | 12.23 B | 3.6699 | 33.795 | 5.6663 | 2.7299 | 3.8194 | 35.7574 | 35.7056 | 25.3775 | 2.989 B | 942.1 M | 1.366 B | 4.284 B | 0.1027 | 0.0904 | 0.095 | 1.5697 | 0.1166 | 0.085 | 0.0455 | 4.3026 | 36.8 | 28.2016 | 0.0354 | 3.0625 | 37.9121 | 18.2657 | 2.8987 | 2.8987 | 18.327 | 38.0393 | 3.0728 | 13.6263 | 0.0263 | 0.0082 | 0.2318 | 2.9363 | 0.5182 | 0.0868 | 1.0633 | 0 | 0 | 0.0058 | 2.2038 | 78 | 56.3447 | 214.561 | 4.6407 | 6.4779 | 1.7011 | 861.55 M | 268.75 M | 972.9 M | 54.2991 | 0.447 | 0.2118 |
| 2023-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2022-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2021-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
| 2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
📊 Explore more key metrics for bioMérieux!
Sign up for free or log in🙌 Join now to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" at no cost